100
Participants
Start Date
February 27, 2017
Primary Completion Date
May 25, 2020
Study Completion Date
May 25, 2020
EORTC QLQ CX-24
Disease specific Patient Reported Outcome measurement tool developed by the European Organization for Research and Treatment of Cancer (EORTC). This questionnaire covers symptoms common to women with cervical cancer and captures the impact of disease and/or treatment on domains including: urologic and gastro-intestinal symptoms, sexual functioning and body image.
Physician Feedback Form
This Feedback form to be completed by oncologists who have had at least one consenting patient participating in this study.
Royal Victoria Regional Health Centre, Barrie
Sunnybrook Research Institute, Toronto
Princess Margaret Cancer Centre, Toronto
University Health Network, Toronto
OTHER